Scholars Central

ArticlePublished 25 Mar 2023

Switching among rheumatologists' perceptions of non-medical tradition and biosimilar biologics

Authors: Mohammed A Omair

International Journal of Clinical Rheumatology

Volume 18 · Issue 3 · Pages 48–50

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background The end of this study was to estimate rheumatologists’ comprehensions of biosimilar biologics and on-Medical Switching (NMS). Methods Across-sectional check was conducted among listed members of the Saudi Society for Rheumatology. The questionnaire concentrated on biosimilars and NMS. Logistic retrogression was performed to ascertain the effect of demographics and practice characteristics on the use of biosimilars and NMS. Results Out of 249 SSR members, 143 completed the check, generating a response rate of57.4. Of those (59.44) were men with a mean (± SD) age and times of practice of42.3 ±9.13 and10.3 ±8.9, independently. Rheumatologists managing adult cases (81.82) and Ministry of Health practice (43.36) were the maturity of repliers. Former experience in defining a biosimilar was reported by 43(30.07) actors, with a advanced probability among women (p = 0.015). An aggregate of 26(18.18) actors had performed NMS on eligible cases. Acceptable knowledge on biosimilars was reported by 69(48.25) actors. The acceptability of substantiation to grant biosimilar blessing for the studied suggestion and extrapolation to treat other conditions was reported by 88(61.5) and 69(48.3), independently. The conception of summation- of- the- substantiation was well understood by37.1. Biosimilars had been preliminarily used by 43(30.07) actors in their practice. NMS had been tried by 26(18.18), while 86(60.1) actors believed that NMS might harm cases. Conclusion There's a clear knowledge gap about the biosimilar blessing process among adult and pediatric rheumatologists who took part in the check. In addition, a large number of actors reported having negative opinions about NMS. There's a need to organize SSR- led educational conditioning, and develop public guidelines regarding biosimilars and NMS

Subjects

Rheumatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Clinical Rheumatology
  • SubjectRheumatology
  • BylineArticles whose byline prints “Mohammed A Omair”